Endometrial thickness and outcome in sub-fertile women treated with clomiphene citrate
- PMID: 19003660
- DOI: 10.1080/01443610802355718
Endometrial thickness and outcome in sub-fertile women treated with clomiphene citrate
Abstract
There is conflicting evidence in the published literature regarding the effects of clomiphene citrate (CC) on endometrial development and its impact on conception. CC is an anti-oestrogen that is commonly used in assisted reproduction to induce ovulation for a range of conditions. The setting was the Reproductive Medicine department at the Royal Blackburn Hospital (RBH). This retrospective cohort study set out to assess the relationship between endometrial thickness (EMT) as measured by trans-vaginal ultrasound scan and pregnancy rates in 81 sub-fertile women treated with CC and to review some of the current literature. Using analysis of logistic regression, the results showed a 14% increase in the odds of conception for each millimetre increase in EMT when the confounding variables of age, basal follicle-stimulating hormone level and body mass index were corrected for. There is good evidence of a positive relationship between greater EMT (within normal limits) and the probability of success. EMT on its own cannot thus far be used to estimate the probability of conception, rather it seems that changes on a microscopic level give better clues to endometrial quality. Taking into account the limitations of patient selection and some missing data, this study should be viewed as a pilot for future investigation.
Similar articles
-
Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio.Fertil Steril. 2006 Feb;85(2):511-3. doi: 10.1016/j.fertnstert.2005.08.016. Fertil Steril. 2006. PMID: 16595244
-
Administration of clomiphene citrate in patients with polycystic ovary syndrome, without inducing withdrawal bleeding, achieves comparable treatment characteristics and outcome.Fertil Steril. 2010 Apr;93(6):2077-9. doi: 10.1016/j.fertnstert.2009.08.019. Epub 2009 Sep 3. Fertil Steril. 2010. PMID: 19732872 Clinical Trial.
-
Aromatase inhibitors for ovulation and pregnancy in polycystic ovary syndrome.Ann Pharmacother. 2009 Jul;43(7):1338-46. doi: 10.1345/aph.1M096. Epub 2009 Jul 7. Ann Pharmacother. 2009. PMID: 19584394 Review.
-
Experience of clomiphene use in a district general hospital.J Obstet Gynaecol. 2010 Jan;30(1):46-8. doi: 10.3109/01443610903267499. J Obstet Gynaecol. 2010. PMID: 20121504
-
Consensus on infertility treatment related to polycystic ovary syndrome.Fertil Steril. 2008 Mar;89(3):505-22. doi: 10.1016/j.fertnstert.2007.09.041. Epub 2008 Feb 20. Fertil Steril. 2008. PMID: 18243179
Cited by
-
The association between endometrial thickness and pregnancy outcome in gonadotropin-stimulated intrauterine insemination cycles.Reprod Biol Endocrinol. 2019 Jan 23;17(1):14. doi: 10.1186/s12958-019-0455-1. Reprod Biol Endocrinol. 2019. PMID: 30674305 Free PMC article.
-
The impact of clomiphene citrate on the endometrium in comparison to gonadotropins in intrauterine insemination cycles: is it thinner and does it matter?Front Endocrinol (Lausanne). 2024 Jun 24;15:1414481. doi: 10.3389/fendo.2024.1414481. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38978628 Free PMC article.
-
Platelet-Rich plasma as an effective alternative approach for improving endometrial receptivity - a clinical retrospective study.JBRA Assist Reprod. 2020 Oct 6;24(4):442-446. doi: 10.5935/1518-0557.20200026. JBRA Assist Reprod. 2020. PMID: 32293825 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical